CIK 0001093557 · Large accelerated filer
DEXCOM INC
Sign in to watch- Ticker
- DXCM
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330857544
- Phone
- 8582000200
- Business address
- 6340 SEQUENCE DRIVE, SAN DIEGO, CA, 92121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,328,435
- in 8 filings, $4.3M under 10b5-1 plans
Net −$4,328,435. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- SAYER KEVIN R −$2.4M Executive Chair sold 8% of stake
- AUGUSTINOS NICHOLAS −$680K Director sold 22% of stake
- Stern Sadie −$649K EVP Chief People & Culture Off sold 6% of stake
- Sylvain Jereme M −$303K EVP, Chief Financal Officer sold 2% of stake
- Brown Michael Jon −$288K EVP Chief Legal Compliance Off sold 3% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-10 | KAHN BARBARA Director | Sale | −200 | $440.85 | $88K | 7,066 |
| 2022-02-10 | KAHN BARBARA Director | Sale | −476 | $442.18 | $210K | 6,590 |
| 2022-02-10 | KAHN BARBARA Director | Sale | −1,147 | $434.36 | $498K | 5,443 |
| 2022-02-10 | KAHN BARBARA Director | Sale | −443 | $443.56 | $196K | 5,000 |
| 2022-02-10 | KAHN BARBARA Director | Sale | −400 | $444.80 | $178K | 4,600 |
| 2022-02-10 | KAHN BARBARA Director | Sale | −200 | $445.85 | $89K | 4,400 |
| 2022-02-10 | KAHN BARBARA Director | Sale | −200 | $447.35 | $89K | 4,200 |
| 2022-02-10 | KAHN BARBARA Director | Sale | −400 | $448.98 | $180K | 3,800 |
| 2022-02-10 | KAHN BARBARA Director | Sale | −200 | $450.07 | $90K | 3,600 |
| 2022-02-10 | KAHN BARBARA Director | Sale | −200 | $451.29 | $90K | 3,400 |
| 2022-02-10 | KAHN BARBARA Director | Sale | −400 | $452.50 | $181K | 3,000 |
| 2022-01-24 | Pacelli Steven Robert Managing Dir., Dexcom Ventures | Sale | −250 | $416.77 | $104K | 34,620 |
| 2022-01-18 | SAYER KEVIN R Chairman, CEO & President | Sale | −3,000 | $438.81 | $1.3M | 78,705 |
| 2022-01-18 | SAYER KEVIN R Chairman, CEO & President | Grant or award | +38,586 | 117,291 | ||
| 2022-01-18 | SAYER KEVIN R Chairman, CEO & President | Sale | −19,674 | $435.06 | $8.6M | 97,617 |
| 2021-12-23 | Pacelli Steven Robert Managing Dir., Dexcom Ventures | Sale | −250 | $573.91 | $143K | 34,870 |
| 2021-12-15 | Leach Jacob Steven EVP Chief Technology Officer | Grant or award | +2,925 | $0.00 | $3 | 72,247 |
| 2021-12-15 | Sylvain Jereme M EVP, Chief Financial Officer | Grant or award | +2,925 | $0.00 | $3 | 15,217 |
| 2021-12-15 | Flynn Paul R EVP, Global Revenue | Grant or award | +2,925 | $0.00 | $3 | 13,853 |
| 2021-12-15 | Patterson Chad EVP, Global Marketing | Grant or award | +2,925 | $0.00 | $3 | 12,528 |
Page 27 of 40 · 785 trades